Compare Stocks: SPEB, IFRX, BG, and MRM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BG Bunge Global	$122.54 -1.6%	$115.19	$76.01 ▼ $134.87	$23.52B	0.67	1.52 million shs	1.21 million shs
IFRX InflaRx	$2.09 +2.0%	$2.00	$0.80 ▼ $2.95	$308M	2.52	786,067 shs	334,148 shs
MRM Medirom Healthcare Technologies	$0.83 -5.7%	$0.97	$0.79 ▼ $4.45	$23.56M	1.05	23,143 shs	11,700 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BG Bunge Global	0.00%	+3.00%	+8.59%	-3.61%	+48.71%
IFRX InflaRx	0.00%	-5.86%	+3.98%	+30.63%	+32.28%
MRM Medirom Healthcare Technologies	0.00%	-12.08%	-18.63%	-29.66%	+82,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BG Bunge Global	$122.54 -1.6%	$115.19	$76.01 ▼ $134.87	$23.52B	0.67	1.52 million shs	1.21 million shs
IFRX InflaRx	$2.09 +2.0%	$2.00	$0.80 ▼ $2.95	$308M	2.52	786,067 shs	334,148 shs
MRM Medirom Healthcare Technologies	$0.83 -5.7%	$0.97	$0.79 ▼ $4.45	$23.56M	1.05	23,143 shs	11,700 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BG Bunge Global	0.00%	+3.00%	+8.59%	-3.61%	+48.71%
IFRX InflaRx	0.00%	-5.86%	+3.98%	+30.63%	+32.28%
MRM Medirom Healthcare Technologies	0.00%	-12.08%	-18.63%	-29.66%	+82,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BG Bunge Global	2.73	Moderate Buy	$129.33	5.54% Upside
IFRX InflaRx	2.63	Moderate Buy	$7.33	250.88% Upside
MRM Medirom Healthcare Technologies	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SPEB, IFRX, BG, and MRM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/10/2026	BG Bunge Global	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$145.00 ➝ $155.00
9/10/2026	BG Bunge Global	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$115.00
9/7/2026	BG Bunge Global	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/25/2026	MRM Medirom Healthcare Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
8/25/2026	IFRX InflaRx	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2026	BG Bunge Global	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
8/13/2026	BG Bunge Global	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$150.00
8/7/2026	IFRX InflaRx	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$4.00 ➝ $6.00
7/28/2026	BG Bunge Global	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/27/2026	IFRX InflaRx	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
6/29/2026	BG Bunge Global	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

(Data available from 9/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BG Bunge Global	$70.33B	0.33	$10.16 per share	12.06	$89.83 per share	1.36
IFRX InflaRx	$30K	10,266.78	N/A	N/A	$0.65 per share	3.22
MRM Medirom Healthcare Technologies	$54.89M	0.43	$0.10 per share	8.13	$0.23 per share	3.61

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BG Bunge Global	$816M	$5.15	23.79	10.14	N/A	1.10%	9.15%	3.43%	11/4/2026 (Estimated)
IFRX InflaRx	-$51.63M	-$0.58	N/A	N/A	N/A	N/A	-53.56%	-43.02%	11/9/2026 (Estimated)
MRM Medirom Healthcare Technologies	$980K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest SPEB, IFRX, BG, and MRM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/7/2026	Q2 2026	IFRX InflaRx	-$0.0666	-$0.11	-$0.0434	-$0.10	$0.01 million	N/A
7/29/2026	Q2 2026	BG Bunge Global	$1.97	$2.00	+$0.03	$3.47	$22.81 billion	$24.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BG Bunge Global	$2.88	2.35%	+6.81%	55.92%	N/A
IFRX InflaRx	N/A	N/A	N/A	N/A	N/A
MRM Medirom Healthcare Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BG Bunge Global	0.54	1.57	0.64
IFRX InflaRx	N/A	8.22	8.22
MRM Medirom Healthcare Technologies	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BG Bunge Global	86.23%
IFRX InflaRx	42.39%
MRM Medirom Healthcare Technologies	N/A

Insider Ownership

Company	Insider Ownership
BG Bunge Global	0.60%
IFRX InflaRx	16.30%
MRM Medirom Healthcare Technologies	40.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BG Bunge Global	34,000	192.12 million	190.97 million	Optionable
IFRX InflaRx	60	147.37 million	123.35 million	Optionable
MRM Medirom Healthcare Technologies	1,051	28.39 million	16.96 million	N/A

SPEB, IFRX, BG, and MRM Headlines

Recent News About These Companies

Medirom Healthcare Technologies (NASDAQ:MRM) Shares Up 0.5% - Time to Buy?

September 10 at 2:40 AM | americanbankingnews.com

Medirom Healthcare Technologies Inc

August 12, 2026 | livemint.com

MEDIROM Healthcare Technologies, Inc. Sponsored ADR

August 10, 2026 | cnn.com

MEDIROM Healthcare Technologies (MRM) stock forecast and price target

July 23, 2026 | finance.yahoo.com

MEDIROM MOTHER Labs Expands Deployment of "REMONY®" Remote Health Monitoring System in JGSDF 8th Division

June 25, 2026 | globenewswire.com

Micromem Technologies Inc. Update on Wearable Sensing Platform for Defence and Security Application Evaluation

June 23, 2026 | newsfilecorp.comN

Micromem Closes Private Placement

June 18, 2026 | newsfilecorp.comN

MEDIROM Group Reports Q1 2026 Results

May 28, 2026 | globenewswire.com

MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 ...

February 27, 2026 | markets.businessinsider.com

MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

February 27, 2026 | globenewswire.com

MEDIROM Strikes Major World ID Deal to Roll Out Orb Devices Across 3,000 Sites in Japan

January 23, 2026 | tipranks.com

MEDIROM Healthcare Technologies Inc. Partners with Tools for Humanity and World Foundation to Support World ID Adoption Across Japan

January 23, 2026 | quiverquant.comQ

MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity

January 23, 2026 | globenewswire.com

World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s "Orb" Authentication Surpasses 20,000 Cumulative ...

January 9, 2026 | markets.businessinsider.com

World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku's “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months

January 8, 2026 | globenewswire.com

MEDIROM Partners with World on Technology Envisioned by Sam Altman and Alex Blania: Deploying “Proof of Human” Infrastructure throughout Japan

December 29, 2025 | globenewswire.com

MEDIROM Healthcare partners with World Foundation to deploy World ID technologies across Japan

December 29, 2025 | msn.com

Medirom stock jumps 10% after hours on deal to run Sam Altman’s World ‘Proof of Human’ sites in Japan

December 26, 2025 | msn.com

MEDIROM Partners with World

December 26, 2025 | markets.businessinsider.com

MEDIROM Healthcare Technologies Inc. Partners with Tools for Humanity and World Foundation to Launch Proof of Human Technology in Japan

December 26, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

SPEB, IFRX, BG, and MRM Company Descriptions

Bunge Global NYSE:BG

$122.54 -2.05 (-1.64%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$122.94 +0.39 (+0.32%)

As of 09/11/2026 08:00 PM Eastern

Bunge Global SA operates as an agribusiness and food company worldwide. It operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains comprising wheat and corn; and processes oilseeds into vegetable oils and protein meals. This segment offers its products for animal feed manufacturers, livestock producers, wheat and corn millers, and other oilseed processors, as well as third-party edible oil processing and biofuel companies for biofuel production applications. The Refined and Specialty Oils segment sells packaged and bulk oils and fats that comprise cooking oils, shortenings, margarines, mayonnaise, renewable diesel feedstocks, and other products for baked goods companies, snack food producers, confectioners, restaurant chains, foodservice operators, infant nutrition companies, and other food manufacturers, as well as grocery chains, wholesalers, distributors, and other retailers. This segment also refines and fractionates palm oil, palm kernel oil, coconut oil, and shea butter, and olive oil; and produces specialty ingredients derived from vegetable oils, such as lecithin. The Milling segment provides wheat flours and bakery mixes; corn milling products that comprise dry-milled corn meals and flours, wet-milled masa and flours, and flaking and brewer's grits, as well as soy-fortified corn meal, corn-soy blends, and other products; whole grain and fiber ingredients; die-cut pellets; and non-GMO products. The Sugar and Bioenergy segment produces sugar and ethanol; and generates electricity from burning sugarcane bagasse. Bunge Global SA was founded in 1818 and is headquartered in Chesterfield, Missouri.

InflaRx NASDAQ:IFRX

$2.09 +0.04 (+1.95%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$2.08 0.00 (-0.24%)

As of 09/11/2026 07:30 PM Eastern

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.

Medirom Healthcare Technologies NASDAQ:MRM

$0.83 -0.05 (-5.68%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$0.85 +0.02 (+2.41%)

As of 09/11/2026 04:04 PM Eastern

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SPEB, IFRX, BG, and MRM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SPEB, IFRX, BG, and MRM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SPEB, IFRX, BG, and MRM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SPEB, IFRX, BG, and MRM Company Descriptions

Bunge Global NYSE:BG

InflaRx NASDAQ:IFRX

Medirom Healthcare Technologies NASDAQ:MRM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SPEB, IFRX, BG, and MRM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SPEB, IFRX, BG, and MRM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SPEB, IFRX, BG, and MRM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SPEB, IFRX, BG, and MRM Company Descriptions

Bunge Global NYSE:BG

InflaRx NASDAQ:IFRX

Medirom Healthcare Technologies NASDAQ:MRM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools